Lessons and Recommendations from a Pentobarbital Shortage: US and Canada 2021.

Area of Science:

• Veterinary Medicine
• Animal Welfare Science

Background:

• A global shortage of pentobarbital sodium in 2021 significantly impacted veterinary practices and animal care industries in the United States and Canada.
• Pentobarbital sodium is the primary drug used for companion animal euthanasia in North America, making its scarcity a critical issue.
• The decreased availability necessitated drug conservation and the exploration of alternative euthanasia methods across various animal species.

Purpose of the Study:

• To investigate the causes of the 2021 pentobarbital sodium shortage.
• To document the strategies and adjustments implemented by animal care professionals in response to the drug scarcity.
• To provide recommendations for managing future shortages of essential euthanasia agents.

Main Methods:

• Review of supply chain disruptions and contributing factors to the pentobarbital sodium shortage.
• Analysis of industry-wide responses, including conservation efforts and the adoption of alternative euthanasia protocols.
• Collaboration assessment among veterinary medical groups, research institutions, and animal shelters.

Main Results:

• The shortage forced a critical evaluation of euthanasia drug availability and reliance.
• Industries implemented conservation measures and explored alternative agents and methods to maintain humane euthanasia practices.
• Cooperative efforts were essential in adapting to the drug's limited supply.

Conclusions:

• The 2021 pentobarbital sodium shortage highlighted vulnerabilities in the supply chain for critical veterinary drugs.
• Adaptability and inter-industry collaboration were key to mitigating the impact on animal welfare.
• Proactive planning and diversified strategies are crucial for ensuring consistent access to humane euthanasia options in the future.